Item 8.01 Other Events.

On September 2, 2020, Organicell issued a press release in which it announced that the U.S. Food and Drug Administration (FDA) granted emergency, expanded access approval to treat two mild to moderate COVID-19 patients and one "Long Hauler" post COVID-19 patient.

A copy of the Company's press release dated September 2, 2020 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits






(d) Exhibits



Exhibit No   Description

   99.1        Press Release, September 2, 2020

© Edgar Online, source Glimpses